Table V.
Patients' blood tumor makers and biochemical results.
No. | CEA (normal value <5 ng/ml) | Cyfra21-1 (normal value <3.3 ng/ml) | ALB (normal value 35–54 g/l) | LDH (normal value 109–245 U/l) |
---|---|---|---|---|
1 | 0.26 | 5.55 | 41.9 | 163 |
2 | 1.6 | 2.48 | 37.4 | 136 |
3 | 2.0 | 3.8 | 36.5 | 140 |
4 | 4.2 | 7.12 | 37.8 | 162 |
5 | 1.7 | 7.07 | 36.1 | 170 |
6 | 0.5 | 1.85 | 36.3 | 206 |
7 | 6.0 | 3.2 | 39.2 | 194 |
8 | 3.8 | 50.12 | 31.4 | 193 |
9 | 0.7 | 3.14 | 39.6 | 197 |
10 | 2.9 | ND | 43.9 | 257 |
11 | 2.9 | 2.01 | 43.2 | 162 |
12 | 0.2 | 10.22 | 31.0 | 173 |
13 | 0.7 | 2.71 | 42.3 | 222 |
14 | 1.1 | 2.94 | 44.4 | 146 |
Mean ± SD | 2.04±1.72 | 7.86±12.94 | 38.64±4.26 | 180.07±33.74 |
CEA, carcinoembryonic antigen; Cyfra21-1, fragments of cytokeratin-19; ALB, albumin; LDH, lactate dehydrogenase; ND, not done; SD, standard deviation.